Evaluation of high-dose aspirin elimination in the treatment of Kawasaki disease in the incidence of coronary artery aneurysm
Conclusions: We concluded that high dose Aspirin does not have a significant role in preventing coronary arteries abnormalities in Kawasaki disease and giving standard 2 gr/kg/day Intravenous immunoglobulin without high-dose Aspirin in acute-phases therapy does not increase the risk of coronary arteries abnormality.
Source: Annals of Pediatric Cardiology - Category: Cardiology Authors: Farima Sanati Mohammadmehdi Bagheri Shahryar Eslami Ali Khalooei Source Type: research
More News: Aspirin | Cardiology | Clinical Trials | Heart | Kawasaki Disease | Pediatrics | Statistics | Study